(Q43180945)

English

Targeting mitogen-activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems

scientific article published in April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Targeting mitogen-activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Michele T. Yip-Schneider

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

author name string

Matthew Hennig

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Sabrina Wentz

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Huangbing Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

S K Hekmatyar

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Patrick Klein

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Navin Bansal

7

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

C Max Schmidt

8

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

language of work or name

0 references

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1218-1225

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Hepatocellular carcinoma: recent trends in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Hepatocellular carcinoma: current management and future trends.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Surgical resection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Spontaneous regression of a large hepatocellular carcinoma with portal vein tumor thrombi: report of a case

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Increased MAPK expression and activity in primary human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor expression via activation of nuclear factor- B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Targeting the mitogen-activated protein kinase cascade to treat cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Role of transforming growth factor alpha and prostaglandins in preferential growth of preneoplastic rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

21 January 2018

Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Current management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Transforming growth factor alpha (TGFalpha) in hepatocellular carcinomas and adjacent hepatic parenchyma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression of transforming growth factor-alpha in a patient with recurrent hepatocellular carcinoma following partial hepatectomy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of transforming growth factor-alpha and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater ef

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of transforming growth factor-alpha in hepatocellular carcinoma and focal nodular hyperplasia from European patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23470

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.23470

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43180945&oldid=1983004004"